We offer it at our Chatsworth clinic. Below is what it is, who it suits, what the research does and doesn't establish, and when we would send you to something else instead.
A Glassifier® is an in-clinic topical treatment that uses microscopic sponge-derived spicules to press a copper-binding peptide (GHK) past the skin's outer barrier without needles, heat, or a device. It is a cosmetic treatment, not an FDA-cleared medical device, and the published evidence so far is early — one 20-person split-face study and laboratory work in bioprinted skin.
We offer it at our Chatsworth clinic. Below is what it is, who it suits, what the research does and doesn't establish, and when we would send you to something else instead.
Two things are happening at once.
The first is mechanical. Spicules are needle-shaped silica microstructures isolated from the freshwater sponge Spongilla fragilis, published at 150 to 250 micrometers long and 12 to 16 micrometers across — roughly the width of a fine human hair. Pressed into the skin, they open transient microchannels through the outermost layer. They are not dissolved or absorbed; they sit in the outer skin and shed with normal turnover over about three days.
The second is chemical. The GHK peptide is not merely mixed into the powder — it is covalently bonded to those spicules through a disulfide bridge. Disulfide bonds are stable in ordinary conditions but are broken by reducing agents, and the most abundant one inside human cells is glutathione. So the design intent is that the peptide stays attached through manufacture, storage and the trip through the outer skin, and releases once it reaches an environment where glutathione is abundant.
That is the design. Whether it happens exactly that way inside a living face has not been measured — the researchers say so themselves.
No, and the distinction is worth understanding before you book either one.
Microneedling works by injury. A device drives fine needles into the dermis to create controlled wounds, and the visible benefit comes from the body's healing response. A Glassifier is not trying to injure anything — the microchannels are a transport route, and the intended effect comes from what travels through them.
The categories are also different in law. In the United States, microneedling instruments for aesthetic use are regulated as medical devices, and that classification explicitly excludes products intended for the transdermal delivery of cosmetics. A cosmetic topical whose entire purpose is delivery is, by the regulation's own text, the thing the microneedling category carves out. That is why we do not call this "needle-free microneedling," however often you see the phrase.
If you want the full comparison, including where microneedling is the better-evidenced choice, we wrote it out here. Our microneedling and mesoneedling services remain the right answer for a number of concerns.
GHK is a tripeptide — glycine, histidine, lysine — that occurs naturally in human plasma, binds copper readily, and has been studied since the 1970s for its role in skin repair and remodeling.
The difficulty has always been delivery. GHK is hydrophilic, and the stratum corneum is very good at keeping water-loving molecules out. That is its job. A copper peptide sitting in a serum on intact skin is, for the most part, a copper peptide sitting on intact skin.
So every serious clinical use of GHK is really an attempt to solve delivery: inject it, drive it in behind a needling device, or attach it to something that makes its own way through. This is the third route. We also offer GHK-Cu within our peptide therapy program, which takes the first.
Less than the marketing suggests, and we would rather you heard that from us.
The laboratory work is real and carefully done. In a 3D-bioprinted human skin model, the bonded system delivered more than five times as much peptide as a loose mixture of spicules and free peptide. On the benchtop, reduced glutathione accelerated release roughly fourfold while oxidized glutathione did not — an elegant control, because it shows the trigger really is reduction rather than some dull artifact. Type I collagen rose in bioprinted skin, with fibronectin and laminin unchanged, which reads as a selective response rather than general upregulation.
Every one of those findings comes from a benchtop or a printed tissue construct. None of them is a measurement in a person.
The human evidence is a single split-face trial of 20 healthy Asian women over five weekly sessions. Read the design carefully: both sides of every face received the spicule regimen, and the base concentrate already contained glutathione. One side additionally received a multi-ingredient booster. Both sides improved; the booster side improved somewhat more. There was no untreated side, and the sides were not randomized. No participant reported redness, swelling, itching or pain at any measured point — a genuinely encouraging early safety signal, and twenty people over five weeks.
The full evidence review is here, claim by claim, with the model attached to each one.
In our hands this suits people whose complaint is skin quality rather than structure: dull or rough texture, pores that read as visible, early laxity, uneven tone. It is also a sensible option for anyone who wants an actives-driven treatment but can't or won't do needles — patients on anticoagulants, patients who faint at the sight of a syringe, patients who cannot take several days of visible downtime.
It is not the right tool for deep static wrinkles, significant scarring, or meaningful laxity. Those want a laser or an energy device, and we will tell you so rather than sell you this. It is not for anyone in an active acne, eczema or rosacea flare, anyone with open lesions, or anyone with a known sensitivity to silica. We defer it in pregnancy and while breastfeeding, because there is no safety data and our standing position on treatments without safety data is to wait.
About thirty minutes, and no anesthetic.
We cleanse, then mix the solution powder with its concentrate fresh in the room — the material is prepared per treatment, not pre-mixed. It is then pressed into the skin, never rubbed, working chin to cheeks to nose to forehead. The Glutagen booster step goes on under a sheet mask. We finish with a barrier cream and sunscreen.
Expect warmth, a fine prickle and a gritty, sandpapery texture during and after. Some people flush lightly. None of that is a complication.
The gritty feeling is the spicules themselves, physically present in the outer skin, and it fades over roughly three days as the stratum corneum turns over. Most people look slightly pink for a few hours and normal by the next day.
Two instructions matter. Do not rub — no scrubbing, no cleansing brush, no brisk towel-drying — because the material can scratch while it is still there. And do not wash your face for at least six hours afterwards; that is the one timed instruction the published protocol specifies. Daily broad-spectrum sunscreen is not optional afterwards.
The full 72-hour aftercare guide covers what to avoid and for how long, what "purging" does and doesn't mean, and the specific signs worth a phone call.
| Glassifier | Microneedling | Mesoneedling | CO2 Fractional Laser | |
|---|---|---|---|---|
| What it is | Cosmetic topical with sponge spicules | Medical device, fine needles | Needle-delivered actives | Ablative fractional laser |
| Needles | No | Yes | Yes | No (light) |
| Anesthetic | Not typically | Usually topical | Usually topical | Yes |
| Main mechanism | Peptide delivery past the barrier | Controlled micro-injury | Active delivery plus micro-injury | Thermal resurfacing |
| Typical social downtime | Hours to about a day | 1–3 days | 1–3 days | 5–7+ days |
| Best for | Texture, tone, pores, early laxity | Texture, scarring, laxity | Hydration, tone, glow | Deep resurfacing, scarring, wrinkles |
| Evidence base | Early — one small human trial | Extensive | Moderate | Extensive |
| Offered at | Chatsworth | Chatsworth, Santa Barbara | Chatsworth, Santa Barbara | Chatsworth |
Plainly: if your concern is atrophic acne scarring or structural texture, we will recommend microneedling, which has randomized trial evidence behind it. If it is dullness, surface roughness or visible pores and you would rather avoid needles, this is a reasonable choice. If you want the glass-skin look specifically, read this first — no single treatment produces it.
A provider will look at your skin, ask what is actually bothering you, and tell you honestly whether this or something else is the better answer. We offer it at our Chatsworth clinic; it is not yet available in Santa Barbara.
No. Microneedling is a device-based treatment that makes controlled micro-injuries in the skin to trigger a healing response. A Glassifier is a cosmetic topical whose sponge-derived microstructures create transient channels in the outer skin to carry a peptide inward. The categories, the mechanism and the recovery are all different.
Most people describe warmth, tingling and a slightly gritty feeling during application and for a short time after, rather than pain. No injections and no anesthetic are typically involved.
Most people have mild redness and a sandpapery feel for a few hours up to about a day. In the published 20-person study, no participant reported redness, swelling, itching or pain at any measured timepoint across five weekly sessions.
No. It is marketed as a cosmetic topical, which is not a category the FDA reviews before sale. It is not an FDA-cleared medical device, and we will not describe it as one.
The published clinical study used five weekly treatments. Your provider will suggest a course based on your skin and your goals rather than a fixed package.
We defer it. There is no safety data in pregnancy for this product, and our standing position on treatments without that data is to wait.
There is no heat and no light involved, which are the usual sources of pigmentation risk. That said, the published trial enrolled 20 Asian women, so data across the full range of skin tones simply doesn't exist yet. Your provider will talk through what that means for you.
Educational content, not medical advice. A Glassifier treatment is a cosmetic procedure; candidacy depends on your individual skin, history and goals, and should be determined with a qualified clinician. Results vary.